Long-Term Prophylaxis With Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: Is Intramuscular Administration an Option?
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2017.12.180
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2018
Authors
Publisher
Elsevier BV